Rsv Vaccine, Pref A-Pref B, Recombinant Dosage
Medically reviewed by Drugs.com. Last updated on Nov 12, 2024.
Applies to the following strengths: preservative-free 60 mcg-60 mcg
Usual Adult Dose for:
Usual Geriatric Dose for:
Additional dosage information:
Usual Adult Dose for Respiratory Syncytial Virus
Pregnant individuals between 32 and 36 weeks of gestation:
0.5 mL intramuscularly as a single dose.
Use: Active immunization for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth to 6 months of age
Usual Geriatric Dose for Respiratory Syncytial Virus
0.5 mL intramuscularly as a single dose.
Use: For active immunization for the prevention of LRTD caused by RSV in individuals 60 years of age and older
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS: History of a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine.
Safety and efficacy have not been established in patients younger than 60 years, except pregnant individuals at 32 to 36 weeks gestational age.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- For intramuscular administration only.
Storage requirements:
- Store vials before reconstitution at 2C to 8C (36F to 46F) in original carton.
- Do not freeze. Discard if the vaccine is frozen.
- Administer immediately after reconstitution or store vaccine at room temperature for up to 4 hours prior to use. Do not refrigerate.
Reconstitution/preparation techniques:
- The manufacturer's product information should be consulted
General:
- To monitor pregnancy outcomes in individuals exposed to this vaccine during pregnancy, a pregnancy registry has been established. Health care providers or patients can contact 1-800-616-3791 to enroll in or obtain information about the registry.
Patient advice:
- Read the Vaccine Information Statement (VIS) provided or available at (www.cdc.gov/vaccines).
- Discuss and report possible adverse reactions with the healthcare provider.
- A pregnancy exposure registry is available.
Frequently asked questions
- What is the difference between Arexvy and Abrysvo?
- What are the symptoms of respiratory syncytial virus (RSV)?
More about rsv vaccine, pref a-pref b, recombinant
- Check interactions
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- During pregnancy
- Drug class: viral vaccines
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
- Respiratory Syncytial Virus Vaccine monograph
- Respiratory Syncytial Virus Vaccine (mRNA) (AHFS Monograph)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.